Linvoseltamab (LINVO) plus carfilzomib (CFZ) in patients (pts) with relapsed/refractory multiple myeloma (RRMM): Initial results from the LINKER-MM2 trial.


Por: Manier, S, Ocio, EM, Martinez-Chamorro, C, Delimpasi, S, Oriol, A, Dimopoulos, MA, Leleu, XP, Rubinstein, S, Joseph, NS, Mesa, MG, Chakraborty, R, de Larrea, CF, Breazna, A, Drew, J, Boyapati, A, Hazra, A, Kroog, GS, Sarkaria, SM and Rodríguez-Otero, P

Publicada: 1 jun 2025
Resumen:


Filiaciones:
Manier, S:
 Lille Univ Hosp, Hematol Dept, Lille, France

Ocio, EM:
 Hosp Univ Marques Valdecilla Univ Hosp IDIVAL Univ, Serv Hematol & Hemoterapia, Santander, Spain

Martinez-Chamorro, C:
 Hosp Univ Quironsalud Madrid, Hematol Dept, Madrid, Spain

 Univ Europea Madrid, Madrid, Spain

Delimpasi, S:
 Gen Hosp Evangelismos, Dept Hematol & Bone Marrow Transplantat Unit, Athens, Greece

:
 Inst Josep Carreras Hosp Germans Trias I Pujol, Dept Hematol, Inst Catala Oncol, Badalona, Spain

Dimopoulos, MA:
 Natl & Kapodistrian Univ Athens, Alexandra Gen Hosp, Athens, Greece

Leleu, XP:
 University, CHU, Hematol, U1313,CIC 1082, Poitiers, France

Rubinstein, S:
 Univ N Carolina, Dept Hematol Oncol, Durham, NC USA

Joseph, NS:
 Emory Univ, Winship Canc Inst, Atlanta, GA USA

Mesa, MG:
 Vall dHebron Hosp, Hematol Dept, Barcelona, Spain

Chakraborty, R:
 Columbia Univ, Irving Med Ctr, Dept Med, New York, NY USA

de Larrea, CF:
 Univ Barcelona, Hosp Clin Barcelona, Hematol Dept, Amyloid & Myeloma Unit, Barcelona, Spain

 Univ Barcelona, Inst Invest Biomed August Pi I Sunyer, Barcelona, Spain

Breazna, A:
 Regeneron Pharmaceut Inc, Tarrytown, NY USA

Rodríguez-Otero, P:
 Clin Univ Navarra, Dept Hematol, Pamplona, Spain
ISSN: 0732183X





JOURNAL OF CLINICAL ONCOLOGY
Editorial
American Society of Clinical Oncology, 2318 MILL ROAD, STE 800, ALEXANDRIA, VA 22314 USA, Estados Unidos America
Tipo de documento: Meeting Abstract
Volumen: 43 Número: 16_SUPPL
Páginas: 7513-7513
WOS Id: 001690254900024

MÉTRICAS